From David Rubin, MD: The ACG Education Universe is a robust online educational library featuring video presentations from ACG’s national and regional meetings. It provides a wealth of content available FREE to ACG members. Sorry, you must be an ACG member. Each week there will be a select video. This Week: “Quality in the GI Practice,” with
Continued Antiplatelet Therapy Does Not Boost Bleeding Risk in GI Procedures
Patients on continuous antiplatelet therapy before gastrointestinal procedures or surgery did not have a higher risk of intra-operative or post-procedure bleeding, compared with those who did not use the drugs, researchers reported. Data from 17 of 22 studies that focused on surgeries and on endoscopic procedures performed mostly by gastroenterologists showed no statistically significant difference
A recent clinical study in Clinical Gastroenterology and Hepatology found that diverticulitis only occurs in about 4% of people. Small pouches, or diverticula, may form in the weak areas of the large intestinal walls (the colon). For most people, the pouches do not become an issue and it is known as diverticulosis. For 5-25% of
Coffee consumption linked to lower risk of colorectal cancer but higher risk of GERD
Source: Coffee consumption linked to lower risk of colorectal cancer | CTV News A new U.S. study has found more evidence for the health-giving properties of coffee, finding that more than 2.5 cups of coffee a day can significantly decrease your risk of colorectal cancer. But we all know coffee increases symptomatic reflux. It seems
Failed Hepatitis C therapy increases risk for hepatocellular carcinoma
Patients with hepatitis C virus infection who failed interferon-free therapy have an increased risk for a specific type of carcinoma of the liver compared with patients who achieved sustained virologic response, according to recently published data.
The biggest admitted downside of PPI therapy at their introduction was cost. With the advent of over-the-counter and generic PPI’s, cost took a back seat and many more patients were managed on chronic, long-term PPI’s with no real attempt to stop or decrease that therapy. Over the past several years, a number of potential adverse
